2Seventy Bio Performance

TSVTDelisted Stock  USD 5.00  0.00  0.00%   
The firm shows a Beta (market volatility) of 0.47, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, 2Seventy Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding 2Seventy Bio is expected to be smaller as well. 2Seventy Bio currently shows a risk of 0.0%. Please confirm 2Seventy Bio sortino ratio, as well as the relationship between the semi variance and day typical price , to decide if 2Seventy Bio will be following its price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days 2Seventy Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, 2Seventy Bio is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
  

2Seventy Bio Relative Risk vs. Return Landscape

If you would invest  500.00  in 2Seventy Bio on December 3, 2025 and sell it today you would earn a total of  0.00  from holding 2Seventy Bio or generate 0.0% return on investment over 90 days. 2Seventy Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than 2Seventy, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

2Seventy Bio Target Price Odds to finish over Current Price

The tendency of 2Seventy Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 5.00 90 days 5.00 
about 26.37
Based on a normal probability distribution, the odds of 2Seventy Bio to move above the current price in 90 days from now is about 26.37 (This 2Seventy Bio probability density function shows the probability of 2Seventy Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days 2Seventy Bio has a beta of 0.47. This usually implies as returns on the market go up, 2Seventy Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding 2Seventy Bio will be expected to be much smaller as well. Moreover 2Seventy Bio has an alpha of 1.406, implying that it can generate a 1.41 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   2Seventy Bio Price Density   
       Price  

Predictive Modules for 2Seventy Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as 2Seventy Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 2Seventy Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
5.005.005.00
Details
Intrinsic
Valuation
LowRealHigh
3.713.715.50
Details
Naive
Forecast
LowNextHigh
4.494.494.49
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.005.005.00
Details

2Seventy Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. 2Seventy Bio is not an exception. The market had few large corrections towards the 2Seventy Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold 2Seventy Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of 2Seventy Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.41
β
Beta against Dow Jones0.47
σ
Overall volatility
1.06
Ir
Information ratio 0.14

2Seventy Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of 2Seventy Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for 2Seventy Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
2Seventy Bio is not yet fully synchronised with the market data
2Seventy Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 37.86 M. Net Loss for the year was (57.25 M) with loss before overhead, payroll, taxes, and interest of (13.24 M).
2Seventy Bio currently holds about 357.93 M in cash with (85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 82.0% of the company shares are owned by institutional investors

2Seventy Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of 2Seventy Stock often depends not only on the future outlook of the current and potential 2Seventy Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. 2Seventy Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding52.2 M
Cash And Short Term Investments174.8 M

2Seventy Bio Fundamentals Growth

2Seventy Stock prices reflect investors' perceptions of the future prospects and financial health of 2Seventy Bio, and 2Seventy Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 2Seventy Stock performance.

About 2Seventy Bio Performance

Assessing 2Seventy Bio's fundamental ratios provides investors with valuable insights into 2Seventy Bio's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the 2Seventy Bio is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2Seventy Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people.

Things to note about 2Seventy Bio performance evaluation

Checking the ongoing alerts about 2Seventy Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 2Seventy Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
2Seventy Bio is not yet fully synchronised with the market data
2Seventy Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 37.86 M. Net Loss for the year was (57.25 M) with loss before overhead, payroll, taxes, and interest of (13.24 M).
2Seventy Bio currently holds about 357.93 M in cash with (85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 82.0% of the company shares are owned by institutional investors
Evaluating 2Seventy Bio's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate 2Seventy Bio's stock performance include:
  • Analyzing 2Seventy Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 2Seventy Bio's stock is overvalued or undervalued compared to its peers.
  • Examining 2Seventy Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating 2Seventy Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 2Seventy Bio's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of 2Seventy Bio's stock. These opinions can provide insight into 2Seventy Bio's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating 2Seventy Bio's stock performance is not an exact science, and many factors can impact 2Seventy Bio's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in 2Seventy Stock

If you are still planning to invest in 2Seventy Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 2Seventy Bio's history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stocks Directory
Find actively traded stocks across global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges